Faculty of Physical Therapy
Dokki, Egypt
Location status: Recruiting
Location contact
Reem Farahat, master
CONTACT
NCT Number: NCT06529185
The aim of this study To show the effect of breather on ventilatory and vascular function in COPD patient with intermittent claudication.
Interested in participating?
Request Info50 year–60 year
Male
Interventional
Not applicable
Dokki, Egypt
Location status: Recruiting
Reem Farahat, master
CONTACT
recent researches show that COPD patients have risk of developing peripheral arterial disease (PAD) which represented on patient by intermittent claudication inspiratory muscle trainer as the breather device show increasing in inspiratory muscle strength and endurance; reduction of dyspnea; and improving of exercise tolerance .
Because of all this things this study tends to show the effect of the breather on ventilatory and vascular function in COPD patient with intermittent claudication.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The BREATHER is Light/Medium resistance inspiratory muscle trainer which has significance role in increasing inspiratory muscle strength and endurance which could result in a decreased sensation of dyspnea
Other names: experimental group
patient will receive the usually pharmacological treatment.
Other names: control group
Time frame: 4 weeks
Spirometry is a physiological test that measures the ability to inhale and exhale air relative to time.
Time frame: 4 weeks
Doppler ultrasound is a simple and non-invasive and method for the evaluation of early atherosclerosis. It can be used as a screening program for PAD in populations with high risk for atherosclerosis.
Time frame: 4 weeks
(5R-STS) test is an objective test of functional impairment commonly used in various diseases including COPD which is used to measure the severity of disease and to monitor recovery.
Time frame: 4 weeks
The results of the tests will be expressed in units of distance that will be walked up to the claudication pain (initial claudication distance) and the maximally tolerated claudication pain (maximal claudication distance).
Contact information is provided by the study sponsor or research team.
Cairo University
Other
Effect of Breather on Ventilatory and Vascular Function in Chronic Obstructive Pulmonary Disease Patients With Intermittent Claudication.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07404826
COPD, Chronic Disease
Cincinnati, Ohio, United States
View Trial DetailsNCT06935825
COPD, Chronic Disease
Amsterdam, Netherlands
View Trial DetailsNCT07566195
COPD, Chronic Disease
Aix-en-Provence, France
View Trial DetailsNCT07567872
COPD, Chronic Disease
Chengdu, Sichuan, China
View Trial Details